ABSTRACT
Simultaneous pancreas-kidney (SPK) transplantation is becoming one of the standard treatment options for patients with type 1 diabetes and end-stage renal disease. More potent immunosuppression protocols, improvements in surgical techniques, and a better understanding of postoperative complications have made SPK transplantation a successful procedure of choice (1-3).
